Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentosan Polysulfate Sodium During Intravesical BCG Therapy in Non-Muscle-Invasive Bladder Cancer
KCT0012273Phase 4Not yet recruiting
- Sponsor
- Chong Kun Dang
- Start
- Aug 2026
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pentosan polysulfate sodium in bladder cancer (2 arms), sponsored by Chong Kun Dang. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
pentosan polysulfate sodium
03
Conditions
bladder cancer
Beyond the preview
Go deeper on KCT0012273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012273.